Study of Relatlimab in Combination With Nivolumab in Chinese Participants

Clinical trial NCT05498480 · COMPLETED

Trial details

NCT number: NCT05498480
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-07-27
Primary completion: 2024-01-18
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.